{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Virtual Drug Trials: In Silico Treatment Optimization\n",
    "\n",
    "## Pharmacological Testing Without Patients\n",
    "\n",
    "This tutorial demonstrates:\n",
    "1. Drug library (7 FDA-approved GI drugs)\n",
    "2. Pharmacokinetics (PK) and pharmacodynamics (PD) modeling\n",
    "3. Single-patient virtual trials\n",
    "4. Cohort-based clinical trials\n",
    "5. Dose-response curves\n",
    "6. Treatment recommendations\n",
    "\n",
    "**Clinical Applications:**\n",
    "- Test drug efficacy *before* prescription\n",
    "- Optimize dosing for individual patients\n",
    "- Screen for non-responders\n",
    "- Predict side effects (multi-target drugs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Imports\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "import sys\n",
    "\n",
    "sys.path.insert(0, '..')\n",
    "\n",
    "from ens_gi_core import ENSGIDigitalTwin\n",
    "from ens_gi_drug_library import (\n",
    "    DrugLibrary, apply_drug, VirtualDrugTrial,\n",
    "    compute_plasma_concentration\n",
    ")\n",
    "\n",
    "print(\"âœ“ Drug library imported successfully\")\n",
    "print(f\"  Available drugs: {len(DrugLibrary.get_all_drugs())}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Part 1: Explore the Drug Library"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# List all available drugs\n",
    "drugs = DrugLibrary.get_all_drugs()\n",
    "\n",
    "print(\"ðŸ“š ENS-GI Drug Library (FDA-Approved):\")\n",
    "print(\"  \" + \"=\"*80)\n",
    "print(f\"  {'Drug':<20} {'Class':<25} {'Indication':<35}\")\n",
    "print(\"  \" + \"-\"*80)\n",
    "\n",
    "for drug in drugs:\n",
    "    print(f\"  {drug.name:<20} {drug.drug_class:<25} {drug.indication:<35}\")\n",
    "\n",
    "print(\"  \" + \"=\"*80)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Part 2: Pharmacokinetics - Drug Absorption and Clearance"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Example: Mexiletine pharmacokinetics\n",
    "mexiletine = DrugLibrary.MEXILETINE\n",
    "\n",
    "print(f\"ðŸ“Š {mexiletine.name} Pharmacokinetics:\")\n",
    "print(f\"  Standard dose: {mexiletine.standard_dose_mg} mg\")\n",
    "print(f\"  Bioavailability: {mexiletine.bioavailability*100:.0f}%\")\n",
    "print(f\"  Half-life: {mexiletine.half_life_hours:.1f} hours\")\n",
    "print(f\"  Volume of distribution: {mexiletine.volume_distribution_L:.0f} L\")\n",
    "\n",
    "# Simulate plasma concentration over time\n",
    "dose_mg = 200  # Standard dose\n",
    "times = np.linspace(0, 24, 100)  # 24 hours\n",
    "concentrations = [compute_plasma_concentration(dose_mg, mexiletine, t) for t in times]\n",
    "\n",
    "# Plot PK curve\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.plot(times, concentrations, linewidth=2, color='blue')\n",
    "plt.xlabel('Time (hours)', fontsize=12)\n",
    "plt.ylabel('Plasma Concentration (ÂµM)', fontsize=12)\n",
    "plt.title(f'{mexiletine.name} Plasma Concentration (200 mg dose)', fontsize=14, fontweight='bold')\n",
    "plt.grid(True, alpha=0.3)\n",
    "\n",
    "# Mark half-life\n",
    "C_max = concentrations[0]\n",
    "C_half = C_max / 2\n",
    "plt.axhline(y=C_half, color='red', linestyle='--', alpha=0.5, label=f'tâ‚/â‚‚ = {mexiletine.half_life_hours:.1f} h')\n",
    "plt.axvline(x=mexiletine.half_life_hours, color='red', linestyle='--', alpha=0.5)\n",
    "plt.legend(fontsize=11)\n",
    "plt.show()\n",
    "\n",
    "print(f\"\\n  C_max (peak): {concentrations[0]:.2f} ÂµM\")\n",
    "print(f\"  C at 12h: {compute_plasma_concentration(dose_mg, mexiletine, 12):.2f} ÂµM\")\n",
    "print(f\"  C at 24h: {compute_plasma_concentration(dose_mg, mexiletine, 24):.2f} ÂµM\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Part 3: Single-Patient Virtual Trial\n",
    "\n",
    "### Case Study: IBS-C Patient Testing Lubiprostone"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "print(\"ðŸ“‹ CASE: 45-year-old female with IBS-C\")\n",
    "print(\"  Symptoms: Constipation, infrequent bowel movements\")\n",
    "print(\"  Prior treatments: Fiber supplements (ineffective)\")\n",
    "print(\"  Considering: Lubiprostone (AmitizaÂ®) 24 mcg BID\\n\")\n",
    "\n",
    "# Create IBS-C patient twin\n",
    "patient = ENSGIDigitalTwin(n_segments=12)\n",
    "patient.apply_profile('ibs_c')\n",
    "\n",
    "# Baseline simulation\n",
    "print(\"Running baseline simulation...\")\n",
    "patient.run(2000, dt=0.05, I_stim={5: 10.0}, verbose=False)\n",
    "baseline_bio = patient.extract_biomarkers()\n",
    "\n",
    "print(\"\\nðŸ“Š Baseline Biomarkers:\")\n",
    "print(f\"  Motility Index: {baseline_bio['motility_index']:.3f}\")\n",
    "print(f\"  ICC Frequency: {baseline_bio['icc_frequency_cpm']:.2f} cpm\")\n",
    "print(f\"  Spike Rate: {baseline_bio['spike_rate_per_neuron']:.3f} Hz\")\n",
    "print(f\"  â†’ Diagnosis: IBS-C (hypoexcitable phenotype)\")\n",
    "\n",
    "# Apply Lubiprostone\n",
    "print(\"\\nApplying Lubiprostone 24 mcg...\")\n",
    "patient_drug = ENSGIDigitalTwin(n_segments=12)\n",
    "patient_drug.apply_profile('ibs_c')\n",
    "\n",
    "drug_info = apply_drug(\n",
    "    patient_drug,\n",
    "    DrugLibrary.LUBIPROSTONE,\n",
    "    dose_mg=0.024,  # 24 mcg\n",
    "    time_hours=2.0\n",
    ")\n",
    "\n",
    "print(f\"  Plasma concentration: {drug_info['concentration_uM']:.4f} ÂµM\")\n",
    "print(f\"  Targets: {drug_info['modified_parameters']}\")\n",
    "\n",
    "# Post-drug simulation\n",
    "patient_drug.run(2000, dt=0.05, I_stim={5: 10.0}, verbose=False)\n",
    "drug_bio = patient_drug.extract_biomarkers()\n",
    "\n",
    "# Compare results\n",
    "print(\"\\nðŸ“Š Post-Treatment Biomarkers:\")\n",
    "print(\"  Biomarker            Baseline    Post-Drug   Change\")\n",
    "print(\"  \" + \"-\"*58)\n",
    "\n",
    "metrics = ['motility_index', 'icc_frequency_cpm', 'spike_rate_per_neuron']\n",
    "for metric in metrics:\n",
    "    baseline = baseline_bio[metric]\n",
    "    post = drug_bio[metric]\n",
    "    change = (post - baseline) / baseline * 100 if baseline != 0 else 0\n",
    "    print(f\"  {metric:<20} {baseline:>10.3f}  {post:>10.3f}   {change:>+6.1f}%\")\n",
    "\n",
    "# Clinical decision\n",
    "improvement = (drug_bio['motility_index'] - baseline_bio['motility_index']) / baseline_bio['motility_index']\n",
    "\n",
    "print(\"\\nðŸ’Š Clinical Recommendation:\")\n",
    "if improvement > 0.20:\n",
    "    print(\"  âœ“ STRONG RESPONDER: Prescribe Lubiprostone 24 mcg BID\")\n",
    "    print(\"    Expected benefit: Significant improvement in bowel transit\")\n",
    "elif improvement > 0.10:\n",
    "    print(\"  ~ MODERATE RESPONDER: Trial Lubiprostone, monitor response\")\n",
    "    print(\"    Consider dose adjustment or combination therapy\")\n",
    "else:\n",
    "    print(\"  âœ— POOR RESPONDER: Consider alternative therapy\")\n",
    "    print(\"    Alternatives: Linaclotide, Prucalopride\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Part 4: Compare Multiple Drugs for IBS-D"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "print(\"ðŸ“‹ CASE: IBS-D Patient - Which drug is best?\\n\")\n",
    "\n",
    "# Create IBS-D baseline\n",
    "ibs_d_patient = ENSGIDigitalTwin(n_segments=10)\n",
    "ibs_d_patient.apply_profile('ibs_d')\n",
    "ibs_d_patient.run(1500, dt=0.05, verbose=False)\n",
    "baseline = ibs_d_patient.extract_biomarkers()\n",
    "\n",
    "# Test multiple drugs\n",
    "drugs_to_test = [\n",
    "    ('Ondansetron', DrugLibrary.ONDANSETRON, 8),  # 8 mg\n",
    "    ('Alosetron', DrugLibrary.ALOSETRON, 1),      # 1 mg\n",
    "    ('Rifaximin', DrugLibrary.RIFAXIMIN, 550),    # 550 mg\n",
    "]\n",
    "\n",
    "results = {}\n",
    "\n",
    "for drug_name, drug, dose in drugs_to_test:\n",
    "    twin_drug = ENSGIDigitalTwin(n_segments=10)\n",
    "    twin_drug.apply_profile('ibs_d')\n",
    "    apply_drug(twin_drug, drug, dose_mg=dose)\n",
    "    twin_drug.run(1500, dt=0.05, verbose=False)\n",
    "    results[drug_name] = twin_drug.extract_biomarkers()\n",
    "\n",
    "# Compare motility reduction\n",
    "print(\"ðŸ“Š Drug Comparison (IBS-D Treatment):\")\n",
    "print(\"  Drug              Dose      Motility Reduction   Efficacy\")\n",
    "print(\"  \" + \"-\"*65)\n",
    "\n",
    "for drug_name, drug, dose in drugs_to_test:\n",
    "    reduction = (baseline['motility_index'] - results[drug_name]['motility_index']) / baseline['motility_index'] * 100\n",
    "    efficacy = \"High\" if reduction > 20 else \"Moderate\" if reduction > 10 else \"Low\"\n",
    "    print(f\"  {drug_name:<16}  {dose:>4} mg   {reduction:>6.1f}%               {efficacy}\")\n",
    "\n",
    "# Visualize\n",
    "drug_names = [name for name, _, _ in drugs_to_test]\n",
    "motility_values = [results[name]['motility_index'] for name in drug_names]\n",
    "motility_values.insert(0, baseline['motility_index'])\n",
    "labels = ['Baseline'] + drug_names\n",
    "\n",
    "plt.figure(figsize=(10, 6))\n",
    "colors = ['red'] + ['green', 'blue', 'orange']\n",
    "bars = plt.bar(labels, motility_values, color=colors, alpha=0.7, edgecolor='black', linewidth=1.5)\n",
    "plt.ylabel('Motility Index', fontsize=12)\n",
    "plt.title('IBS-D Drug Efficacy Comparison', fontsize=14, fontweight='bold')\n",
    "plt.grid(True, axis='y', alpha=0.3)\n",
    "\n",
    "# Add value labels\n",
    "for bar, val in zip(bars, motility_values):\n",
    "    plt.text(bar.get_x() + bar.get_width()/2, val, f'{val:.3f}',\n",
    "             ha='center', va='bottom', fontweight='bold', fontsize=10)\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "print(\"\\nðŸ’Š Recommendation: Alosetron shows strongest effect (5-HT3 antagonist)\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Part 5: Dose-Response Curve"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Generate dose-response curve for Mexiletine in IBS-C\n",
    "print(\"Generating dose-response curve for Mexiletine...\\n\")\n",
    "\n",
    "doses = [0, 50, 100, 150, 200, 250, 300]  # mg\n",
    "responses = []\n",
    "\n",
    "for dose in doses:\n",
    "    twin = ENSGIDigitalTwin(n_segments=8)\n",
    "    twin.apply_profile('ibs_c')\n",
    "    \n",
    "    if dose > 0:\n",
    "        apply_drug(twin, DrugLibrary.MEXILETINE, dose_mg=dose)\n",
    "    \n",
    "    twin.run(1000, dt=0.1, verbose=False)\n",
    "    bio = twin.extract_biomarkers()\n",
    "    responses.append(bio['motility_index'])\n",
    "    print(f\"  Dose {dose:>3} mg â†’ Motility = {bio['motility_index']:.3f}\")\n",
    "\n",
    "# Plot dose-response\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.plot(doses, responses, 'o-', linewidth=2, markersize=10, color='purple')\n",
    "plt.xlabel('Mexiletine Dose (mg)', fontsize=12)\n",
    "plt.ylabel('Motility Index', fontsize=12)\n",
    "plt.title('Dose-Response Curve: Mexiletine in IBS-C', fontsize=14, fontweight='bold')\n",
    "plt.grid(True, alpha=0.3)\n",
    "\n",
    "# Find optimal dose (maximum response)\n",
    "optimal_idx = np.argmax(responses)\n",
    "optimal_dose = doses[optimal_idx]\n",
    "optimal_response = responses[optimal_idx]\n",
    "\n",
    "plt.axvline(x=optimal_dose, color='red', linestyle='--', alpha=0.5,\n",
    "            label=f'Optimal dose = {optimal_dose} mg')\n",
    "plt.axhline(y=optimal_response, color='red', linestyle='--', alpha=0.5)\n",
    "plt.legend(fontsize=11)\n",
    "plt.show()\n",
    "\n",
    "print(f\"\\nðŸ“Š Optimal Dose: {optimal_dose} mg\")\n",
    "print(f\"   Maximum Response: {optimal_response:.3f}\")\n",
    "print(f\"   Improvement over baseline: {(optimal_response - responses[0])/responses[0]*100:.1f}%\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Part 6: Full Virtual Clinical Trial (Cohort-Based)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "print(\"\\n\" + \"=\"*70)\n",
    "print(\"VIRTUAL CLINICAL TRIAL: PRUCALOPRIDE FOR IBS-C\")\n",
    "print(\"=\"*70)\n",
    "print(\"\\nTrial Design:\")\n",
    "print(\"  â€¢ Drug: Prucalopride (5-HT4 agonist)\")\n",
    "print(\"  â€¢ Indication: IBS-C\")\n",
    "print(\"  â€¢ Cohort size: 30 patients\")\n",
    "print(\"  â€¢ Doses: 1 mg, 2 mg, 4 mg\")\n",
    "print(\"  â€¢ Duration: 1000 ms simulation\\n\")\n",
    "\n",
    "# Create virtual trial\n",
    "trial = VirtualDrugTrial(\n",
    "    drug=DrugLibrary.PRUCALOPRIDE,\n",
    "    cohort_size=30,\n",
    "    patient_profile='ibs_c',\n",
    "    parameter_variation=0.15\n",
    ")\n",
    "\n",
    "# Run trial (this may take a few minutes)\n",
    "print(\"Running virtual trial (this will take 2-3 minutes)...\\n\")\n",
    "trial_results = trial.run_trial(\n",
    "    doses_mg=[1, 2, 4],\n",
    "    simulation_duration=1000\n",
    ")\n",
    "\n",
    "# Print results\n",
    "VirtualDrugTrial.print_results(trial_results)\n",
    "\n",
    "# Visualize dose-response\n",
    "doses_tested = list(trial_results.dose_response_curve.keys())\n",
    "responses = list(trial_results.dose_response_curve.values())\n",
    "\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.plot(doses_tested, responses, 'o-', linewidth=2, markersize=12, color='green')\n",
    "plt.xlabel('Prucalopride Dose (mg)', fontsize=12)\n",
    "plt.ylabel('Mean Response (Î” Motility)', fontsize=12)\n",
    "plt.title('Virtual Trial: Prucalopride Dose-Response in IBS-C Cohort (n=30)',\n",
    "          fontsize=14, fontweight='bold')\n",
    "plt.grid(True, alpha=0.3)\n",
    "plt.show()\n",
    "\n",
    "print(\"\\nðŸ’Š Trial Conclusion:\")\n",
    "if trial_results.responder_rate > 0.5:\n",
    "    print(f\"  âœ“ POSITIVE TRIAL: {trial_results.responder_rate*100:.0f}% responder rate\")\n",
    "    print(f\"  âœ“ Recommend: Prucalopride for IBS-C treatment\")\n",
    "else:\n",
    "    print(f\"  âœ— NEGATIVE TRIAL: {trial_results.responder_rate*100:.0f}% responder rate\")\n",
    "    print(f\"  âœ— Consider alternative therapies\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Part 7: Multi-Target Drug Effects"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Alosetron has multiple targets (5-HT3 receptor + excitatory synapses)\n",
    "alosetron = DrugLibrary.ALOSETRON\n",
    "\n",
    "print(f\"ðŸ“Š {alosetron.name} - Multi-Target Analysis\")\n",
    "print(f\"  Number of targets: {len(alosetron.targets)}\\n\")\n",
    "\n",
    "for idx, target in enumerate(alosetron.targets, 1):\n",
    "    print(f\"  Target {idx}: {target.parameter}\")\n",
    "    print(f\"    Type: {target.target_type.value}\")\n",
    "    print(f\"    IC50/EC50: {target.ic50_or_ec50:.2f} ÂµM\")\n",
    "    print(f\"    Efficacy: {target.efficacy*100:.0f}%\")\n",
    "    print()\n",
    "\n",
    "print(\"  Clinical Implication:\")\n",
    "print(\"  â†’ Dual mechanism: Blocks serotonin AND reduces excitatory transmission\")\n",
    "print(\"  â†’ Stronger effect than single-target drugs\")\n",
    "print(\"  â†’ Higher risk of side effects (constipation, ischemic colitis)\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Summary\n",
    "\n",
    "This tutorial demonstrated:\n",
    "\n",
    "1. âœ… **Drug Library** - 7 FDA-approved GI drugs with PK/PD models\n",
    "2. âœ… **Pharmacokinetics** - Plasma concentration curves\n",
    "3. âœ… **Single-Patient Trials** - Personalized drug response\n",
    "4. âœ… **Drug Comparison** - Selecting optimal therapy\n",
    "5. âœ… **Dose-Response Curves** - Finding optimal dosing\n",
    "6. âœ… **Cohort Trials** - Statistical analysis (n=30 patients)\n",
    "7. âœ… **Multi-Target Effects** - Complex drug mechanisms\n",
    "\n",
    "### Clinical Advantages:\n",
    "\n",
    "- **Pre-screening**: Identify non-responders before prescription\n",
    "- **Dose Optimization**: Find patient-specific optimal dose\n",
    "- **Drug Selection**: Compare efficacy across multiple options\n",
    "- **Safety**: Predict side effects from multi-target drugs\n",
    "- **Cost Savings**: Avoid ineffective treatments\n",
    "\n",
    "### Available Drugs:\n",
    "\n",
    "1. **Mexiletine** - Na+ blocker (off-label for IBS)\n",
    "2. **Ondansetron** - 5-HT3 antagonist (IBS-D)\n",
    "3. **Alosetron** - 5-HT3 antagonist (severe IBS-D)\n",
    "4. **Lubiprostone** - ClC-2 activator (IBS-C)\n",
    "5. **Linaclotide** - Guanylate cyclase agonist (IBS-C)\n",
    "6. **Prucalopride** - 5-HT4 agonist (IBS-C)\n",
    "7. **Rifaximin** - Antibiotic (IBS with bloating)\n",
    "\n",
    "### Next Steps:\n",
    "\n",
    "- Add more drugs to library (custom drug profiles)\n",
    "- Model drug-drug interactions\n",
    "- Integrate with real patient data\n",
    "- Prospective clinical validation"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
